What is NDC 72205-055?

72205-055 is the product NDC for pimavanserin, Pimavanserin tartrate 34 mg/1 capsule, listed with the FDA by Novadoz Pharmaceuticals LLC.

Novadoz Pharmaceuticals LLC, NDC labeler code 72205. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for pimavanserin?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

pimavanserin NDC 72205-055 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)72205-055Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72205-0055Add the package segment from the table below.

Product information

Brand name (proprietary): pimavanserin
Generic name (nonproprietary): pimavanserin
Active ingredients: Pimavanserin tartrate — 34 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Novadoz Pharmaceuticals LLCNDC labeler code 72205
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 214925
Marketing start: Jan 16, 2024
Listing expires: Dec 31, 2026
Identifiers: Product ID 72205-055_403b6540-c53d-4e92-91b4-36ca6338b2b1SPL ID 403b6540-c53d-4e92-91b4-36ca6338b2b1SPL set ID 403b6540-c53d-4e92-91b4-36ca6338b2b1RxCUI 2049275UNII NA83F1SJSRUPC 0372205055308
Pharmacologic class: Atypical Antipsychotic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match: No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

Product label

Current FDA label (SPL), effective Nov 1, 2023. This label includes a boxed warning.

Indications (excerpt from the label)

Pimavanserin capsule is indicated for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis [see Clinical Studies (14) ]. Pimavanserin capsule is an atypical antipsychotic indicated for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis. (1)

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 72205-055

What is NDC 72205-055?: 72205-055 is the product NDC for pimavanserin, Pimavanserin tartrate 34 mg/1 capsule, listed with the FDA by Novadoz Pharmaceuticals LLC.
What drug is associated with this NDC?: pimavanserin.
What is the active ingredient?: Pimavanserin tartrate.
Who is the labeler?: Novadoz Pharmaceuticals LLC, NDC labeler code 72205. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for pimavanserin?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.